<SEC-DOCUMENT>0001125345-21-000087.txt : 20210616
<SEC-HEADER>0001125345-21-000087.hdr.sgml : 20210616
<ACCEPTANCE-DATETIME>20210616165520
ACCESSION NUMBER:		0001125345-21-000087
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20210615
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210616
DATE AS OF CHANGE:		20210616

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MACROGENICS INC
		CENTRAL INDEX KEY:			0001125345
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36112
		FILM NUMBER:		211022124

	BUSINESS ADDRESS:	
		STREET 1:		9704 MEDICAL CENTER DRIVE
		CITY:			Rockville
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		301-251-5172

	MAIL ADDRESS:	
		STREET 1:		9704 MEDICAL CENTER DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mgnx-20210615.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:30cd4160-e760-48d5-b5dd-5a3f14681f8b,g:d4939114-b443-463f-a3db-f3bfc26be930,d:371a67b8edf4495b9923ac5ebc250c3e--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mgnx-20210615</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV80L2ZyYWc6Zjg1YzY1OGYwZWFlNDUxMDhlMTYzMmMzMzg5NjZiMDYvdGFibGU6NDU5MzJiMjM5OWQ3NGNjYzg2YjU3NDMxNzdjNjIzODAvdGFibGVyYW5nZTo0NTkzMmIyMzk5ZDc0Y2NjODZiNTc0MzE3N2M2MjM4MF8yLTEtMS0xLTA_3a7039c2-cd68-40b4-8458-d66474e217a0">0001125345</ix:nonNumeric><ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV80L2ZyYWc6Zjg1YzY1OGYwZWFlNDUxMDhlMTYzMmMzMzg5NjZiMDYvdGFibGU6NDU5MzJiMjM5OWQ3NGNjYzg2YjU3NDMxNzdjNjIzODAvdGFibGVyYW5nZTo0NTkzMmIyMzk5ZDc0Y2NjODZiNTc0MzE3N2M2MjM4MF8zLTEtMS0xLTA_01dd32c2-355c-4b3f-aac4-8b0db80414d9">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mgnx-20210615.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125345</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-15</xbrli:startDate><xbrli:endDate>2021-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac630aa87ea54dd0837bf59c917fa538_D20210513-20210513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125345</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-13</xbrli:startDate><xbrli:endDate>2021-05-13</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i371a67b8edf4495b9923ac5ebc250c3e_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQ2_b5ec0961-9811-421c-8d88-90520f44c91e">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Pursuant to Section 13 or 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of report (Date of earliest event reported):&#160; <ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18yMzI_a4b22378-cd3c-43c7-87f0-2513f8cc59b2">June 15, 2021</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQw_0b0e4c6b-27c0-4694-8a7b-d1445627f68a">MACROGENICS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (Exact Name of Registrant as Specified in Charter)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.948%"><tr><td style="width:1.0%"></td><td style="width:18.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.968%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmM3ZTkyY2Q3MWQ4NDlkYTgwNjI3NmYzZmFhMTZkMDYvdGFibGVyYW5nZTpmYzdlOTJjZDcxZDg0OWRhODA2Mjc2ZjNmYWExNmQwNl8wLTAtMS0xLTA_5e1296db-3cf7-427d-9c9c-397a88ef5f61">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmM3ZTkyY2Q3MWQ4NDlkYTgwNjI3NmYzZmFhMTZkMDYvdGFibGVyYW5nZTpmYzdlOTJjZDcxZDg0OWRhODA2Mjc2ZjNmYWExNmQwNl8wLTMtMS0xLTA_c840b874-b00e-4784-9573-4ddc32f28dc6">001-36112</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmM3ZTkyY2Q3MWQ4NDlkYTgwNjI3NmYzZmFhMTZkMDYvdGFibGVyYW5nZTpmYzdlOTJjZDcxZDg0OWRhODA2Mjc2ZjNmYWExNmQwNl8wLTUtMS0xLTA_e07a881e-860f-4155-a124-79e2507b491c">06-1591613</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(IRS Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;Identification No.)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmM3ZTkyY2Q3MWQ4NDlkYTgwNjI3NmYzZmFhMTZkMDYvdGFibGVyYW5nZTpmYzdlOTJjZDcxZDg0OWRhODA2Mjc2ZjNmYWExNmQwNl8zLTAtMS0xLTA_56cca759-e6d8-4fce-bbb6-6c4f0a395115">9704 Medical Center Drive</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmM3ZTkyY2Q3MWQ4NDlkYTgwNjI3NmYzZmFhMTZkMDYvdGFibGVyYW5nZTpmYzdlOTJjZDcxZDg0OWRhODA2Mjc2ZjNmYWExNmQwNl80LTAtMS0xLTA_b6f943d2-9b75-4cde-b515-4ad099b35758">Rockville,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmM3ZTkyY2Q3MWQ4NDlkYTgwNjI3NmYzZmFhMTZkMDYvdGFibGVyYW5nZTpmYzdlOTJjZDcxZDg0OWRhODA2Mjc2ZjNmYWExNmQwNl80LTEtMS0xLTA_63cb901f-eb5a-4b84-a73f-1a255b0111c3">Maryland</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmM3ZTkyY2Q3MWQ4NDlkYTgwNjI3NmYzZmFhMTZkMDYvdGFibGVyYW5nZTpmYzdlOTJjZDcxZDg0OWRhODA2Mjc2ZjNmYWExNmQwNl80LTMtMS0xLTA_f2d38b8d-c7ba-4030-b9a2-0275a0ba0bf1">20850</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code:&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="iac630aa87ea54dd0837bf59c917fa538_D20210513-20210513" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQ3_0080d96e-2a4e-4df8-9a35-7228e011b279">301</ix:nonNumeric>) <ix:nonNumeric contextRef="iac630aa87ea54dd0837bf59c917fa538_D20210513-20210513" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQx_0c2d6536-bdb6-41cd-ab25-86ae27af4511">251-5172</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not applicable&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmY1ODQyYjYwNDQwNGQ5YTk1NTkzZWQ5M2RhNzc4OGIvdGFibGVyYW5nZTpmZjU4NDJiNjA0NDA0ZDlhOTU1OTNlZDkzZGE3Nzg4Yl8xLTAtMS0xLTA_f2f06d28-9109-4768-a2f9-695e279c750c">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmY1ODQyYjYwNDQwNGQ5YTk1NTkzZWQ5M2RhNzc4OGIvdGFibGVyYW5nZTpmZjU4NDJiNjA0NDA0ZDlhOTU1OTNlZDkzZGE3Nzg4Yl8xLTEtMS0xLTA_b21fed8d-0c2b-49f8-8d64-23d3ae98d17b">MGNX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmY1ODQyYjYwNDQwNGQ5YTk1NTkzZWQ5M2RhNzc4OGIvdGFibGVyYW5nZTpmZjU4NDJiNjA0NDA0ZDlhOTU1OTNlZDkzZGE3Nzg4Yl8xLTItMS0xLTA_4649c1aa-74aa-48ff-9bfd-32ee68941846">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:5.25pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-bottom:3pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQ4_79f7b69f-19e5-411b-91ea-bbb84460a4df">&#9744;</ix:nonNumeric> Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:3pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQy_afaa3101-c680-475f-b9d8-ac737826128e">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:3pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQz_62072e81-f757-4b20-8b5f-b3c8a7a1fd5d">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQ0_b36b260b-0be7-4512-bf8b-edb1c2d80b13">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  <ix:nonNumeric contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQ1_e813195a-e881-4fb3-9e00-ba14308013b4">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   &#9744;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i371a67b8edf4495b9923ac5ebc250c3e_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Item 1.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Entry into a Material Definitive Agreement.</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">On </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">June&#160;15, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">, MacroGenics, Inc. (the &#8220;Company&#8221;) entered into a collaboration and license agreement (the &#8220;Agreement&#8221;) with Zai Lab US LLC (&#8220;Zai&#8221;) pursuant to which the Company and Zai agreed to collaboratively develop and commercialize up to four bispecific antibody-based molecules based on the Company&#8217;s proprietary DART&#174; and TRIDENT&#174; multi-specific technology platforms. Under the Agreement, each party agrees to contribute specified intellectual property to enable the research, development, manufacture and commercialization of up to four future CD3 or CD47-based bispecific molecule</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">. Zai will be granted exclusive rights in Greater China, Japan, and Korea for two programs and exclusive global rights for two other programs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As previously disclosed, in November 2018, the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">entered into a collaboration and license agreement with Zai Lab Limited under which Zai Lab Limited obtained regional development and commercialization rights in mainland China, Hong Kong, Macau and Taiwan for (i) margetuximab, an immune-optimized anti-HER2 monoclonal antibody, (ii) tebotelimab (formerly known as MGD013), a bispecific DART molecule designed to provide coordinate blockade of PD-1 and LAG-3 for the potential treatment of a range of solid tumors and hematological malignancies, and (iii) an undisclosed, multi-specific TRIDENT molecule in preclinical development.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As consideration for the rights granted to Zai under the Agreement, Zai agreed to pay to the Company a non-creditable, non-refundable upfront payment of $25.0 million. Further, on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">June&#160;15, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">, as partial consideration for the rights granted to Zai under the Agreement, the Company entered into a stock purchase agreement (the &#8220;Stock Purchase Agreement&#8221;) with Zai, pursuant to which the Company agreed to issue and sell to Zai in a private placement an aggregate of 958,467 newly issued shares of common stock, par value $0.01 per share, of the Company (the &#8220;Shares&#8221;), with a per share purchase price of $31.30 (the &#8220;Private Placement&#8221;), for aggregate gross proceeds of approximately $30 million (collectively, the &#8220;Offering&#8221;). The closing of the Offering is expected to occur by the end of the second quarter of 2021.   </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Zai is also required to make payments to the Company of up to an aggregate of $1.4 billion upon the achievement of potential development, regulatory and commercial milestones specified in the Agreement. The Agreement additionally provides that Zai is obligated to pay to the Company royalties at tiered percentage rates on annual net sales of specified products, subject to reduction under specified circumstances. The Company granted to Zai an option to convert the royalty arrangement for the lead research molecule to a global 50/50 profit and loss sharing arrangement by making a payment of approximately $85 million.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The Agreement will generally terminate on a program-by-program and country-by-country or region-by-region basis, with certain exceptions, upon the later to occur of (i) the date that is 12 years after the date of the first commercial sale of the product in the applicable country or region, (ii) the date of expiration of the last valid claim covering such product with a licensed patent in the applicable country or region and (iii) the expiration date of any data exclusivity period for such product in the applicable country or region. For certain programs, Zai may terminate the Agreement, in whole or in part, after the second or fourth anniversary of the date of the Agreement by providing 90 days&#8217; written notice to the Company and, upon other conditions, after the second anniversary of the date of the Agreement with 180 days&#8217; written notice to the Company. The Company may terminate the Agreement on a collaboration product-by-collaboration product upon 90 days&#8217; written notice if a major safety issue has occurred with respect to the collaboration product. Either party may terminate the Agreement upon a material breach by the other party that remains uncured or upon certain bankruptcy events. In addition, the Company may terminate the Agreement if Zai challenges the licensed patent rights.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The foregoing descriptions of the Agreement and the Stock Purchase Agreement, as well as the transactions contemplated therein, are qualified in their entirety by reference to the full text of the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">agreements, copies of which will be filed as exhibits to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Item 3.02</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Unregistered Sales of Equity Securities.</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The disclosure set forth above under Item 1.01 is incorporated herein by reference. The Company&#8217;s offering and sale of the Shares in the Private Placement were made in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Item 8.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Other Events.</span></div></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">On June 16, 2021, the Company issued a press release (the &#8220;Press Release&#8221;) announcing the Agreement. The full text of the Press Release is attached as Exhibit 99.1 to this Current Report on Form 8-K (the &#8220;Form 8-K&#8221;) and incorporated herein by reference.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">Forward-Looking Statements</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">This Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934. These include statements about future expectations, plans and prospects for the Company, including statements about the Company&#8217;s strategy, future operations, clinical development of its therapeutic candidates, milestone, royalty or opt-in payments from the Company&#8217;s collaborators, the Company&#8217;s anticipated milestones[, the expected closing of the Offering] and future expectations and plans and prospects for the Company. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: risks that MARGENZA revenue, expenses and costs may not be as expected, risks relating to MARGENZA&#8217;s market acceptance, competition, reimbursement and regulatory actions, the uncertainties inherent in the initiation and enrollment of future clinical trials, expectations of expanding ongoing clinical trials, availability and timing of data from ongoing clinical trials, expectations for regulatory approvals, other matters that could affect the availability or commercial potential of the Company's product candidates and other risks described in the Company's filings with the Securities and Exchange Commission. In addition, the forward-looking statements included in this Form 8-K represent the Company's views only as of the date hereof. The Company anticipates that subsequent events and developments will cause the Company's views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so, except as may be required by law. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date hereof.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.676%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Item 9.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Financial Statements and Exhibits</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(d)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibits.</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:21.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Description of Exhibit</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="mgnx_zlabxjointreleasex16j.htm">99.1</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="mgnx_zlabxjointreleasex16j.htm">Press Release dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="mgnx_zlabxjointreleasex16j.htm">June 16</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="mgnx_zlabxjointreleasex16j.htm">, 2021</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cover Page Interactive Data (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i371a67b8edf4495b9923ac5ebc250c3e_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MACROGENICS, INC.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date:  June 16, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By:</span></div><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name:</span></div><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ Jeffrey Peters</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Jeffrey Peters</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vice President and General Counsel</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>mgnx_zlabxjointreleasex16j.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ia72f648ed8b34e3bbf87f04df1a1bd03_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 99.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:133%">MacroGenics and Zai Lab Enter Into Broad Strategic Collaboration to Develop and Commercialize Preclinical Bispecific Antibodies in Oncology</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8211;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:133%;padding-left:11.33pt">Zai Lab granted combination of regional Asian and global rights for up to four CD3- or CD47-based bispecific molecules</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8211;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:133%;padding-left:11.33pt">MacroGenics provides rights to Zai Lab for its DART&#174; and TRIDENT&#174; multi-specific platforms and a lead research program targeting solid tumors </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8211;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:133%;padding-left:11.33pt">Zai Lab provides rights to MacroGenics for certain intellectual property related to CD47 for select tumor targets</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">ROCKVILLE, MD, SHANGHAI and SAN FRANCISCO, June 16, 2021 (GLOBE NEWSWIRE) &#8211; MacroGenics (NASDAQ&#58; MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal-antibody-based therapeutics for the treatment of cancer, and Zai Lab Limited (NASDAQ&#58; ZLAB&#59; HKEX&#58; 9688), an innovative commercial-stage biopharmaceutical company, announced today that the companies have entered into an exclusive collaboration and license agreement involving up to four immuno-oncology molecules. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The first collaboration program covers a lead research molecule that incorporates MacroGenics&#8217; DART platform and binds CD3 and an undisclosed target that is expressed in multiple solid tumors. The next-generation CD3 component of the DART bispecific molecule has been designed to minimize cytokine-release syndrome while maintaining anti-tumor cytolytic activity. The second collaboration program will cover a target to be designated by MacroGenics. For both molecules, Zai receives commercial rights in Greater China, Japan, and Korea and MacroGenics receives commercial rights in all other territories. For the lead molecule, Zai Lab receives an option upon reaching a predefined clinical milestone to convert the regional arrangement into a global 50&#47;50 profit share.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Zai Lab also obtains exclusive, global licenses from MacroGenics to develop, manufacture and commercialize two additional molecules. For the four programs, each company will contribute intellectual property to generate either CD3- or CD47-based bispecific antibodies.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8220;We are very pleased to be expanding our existing relationship with Zai Lab, which already includes regional rights in Greater China for two clinical-stage programs,&#8221; said Scott Koenig, M.D., Ph.D., President and Chief Executive Officer of MacroGenics. &#8220;Zai has a strong track record of rapidly progressing the development of innovative product candidates in China. This new partnership enables us to jointly discover, develop and deliver potentially best-in-class therapeutics to address patients&#8217; unmet medical needs.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8220;MacroGenics has been a great partner and one of the leading companies in the immuno-oncology field,&#8221; said Samantha Du, Ph.D., Founder, Chairperson, Chief Executive Officer of Zai </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-right:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Lab.  &#8220;We are pleased to expand our strategic collaboration, which leverages both companies&#8217; unique research capabilities and gives Zai Lab access to MacroGenics&#8217; proprietary technologies to expand our innovative oncology portfolio on a global basis.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Under the terms of the agreement, MacroGenics receives initial consideration from Zai Lab of $55 million, including an upfront payment of $25 million and an equity investment of $30 million in MacroGenics&#8217; common stock at $31.30 per share. In addition, MacroGenics is eligible to receive up to $1.4 billion in potential development, regulatory and commercial milestone payments for the four programs. If products from the collaboration are commercialized, MacroGenics would also receive royalties on annual net sales in Zai Lab&#8217;s territories.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">About&#8239;MacroGenics, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">MacroGenics is a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. For more information, please see the Company's website at www.macrogenics.com. MacroGenics, the MacroGenics logo, DART and TRIDENT are trademarks or registered trademarks of MacroGenics, Inc.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">About Zai Lab</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Zai Lab (NASDAQ&#58; ZLAB&#59; HKEX&#58; 9688) is an innovative commercial-stage biopharmaceutical company focused on bringing transformative medicines for cancer and infectious and autoimmune diseases to patients in China and around the world. We aim to address significant unmet medical needs in large, fast-growing segments of the pharmaceutical market. Our experienced team has secured partnerships with leading global biopharmaceutical companies to generate a broad pipeline of potentially innovative, marketed products and product candidates. We have also built an in-house team with strong drug discovery and translational research capabilities and are establishing a pipeline of proprietary drug candidates with global rights. Our vision is to become a leading global biopharmaceutical company, discovering, developing, manufacturing and commercializing our portfolio in order to positively impact human health worldwide. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">For additional information about the company, please visit www.zailaboratory.com or follow us at www.twitter.com&#47;ZaiLab_Global.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">MacroGenics Forward-Looking Statements</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Any statements in this press release about future expectations, plans and prospects for the Company, including statements about the Company's strategy, future operations, clinical development of the Company's therapeutic candidates, commercial prospects of or product revenues from MARGENZA, milestone or opt-in payments from the Company's collaborators, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-right:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">the Company's anticipated milestones and other statements containing the words &#34;subject to&#34;, &#34;believe&#34;, &#34;anticipate&#34;, &#34;plan&#34;, &#34;expect&#34;, &#34;intend&#34;, &#34;estimate&#34;, &#34;project&#34;, &#34;may&#34;, &#34;will&#34;, &#34;should&#34;, &#34;would&#34;, &#34;could&#34;, &#34;can&#34;, the negatives thereof, variations thereon and similar expressions, or by discussions of strategy constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including&#58; risks that MARGENZA revenue, expenses and costs may not be as expected, risks relating to MARGENZA&#8217;s market acceptance, competition, reimbursement and regulatory actions, the uncertainties inherent in the initiation and enrollment of future clinical trials, expectations of expanding ongoing clinical trials, availability and timing of data from ongoing clinical trials, expectations for regulatory approvals, other matters that could affect the availability or commercial potential of the Company's product candidates and other risks described in the Company's filings with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the Company's views only as of the date hereof. The Company anticipates that subsequent events and developments will cause the Company's views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so, except as may be required by law. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date hereof.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Zai Lab Forward-Looking Statements</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">This press release contains statements about future expectations, plans and prospects for Zai Lab, including, without limitation, statements regarding the prospects and plans for developing and commercializing the preclinical bispecific antibody-based molecules and other statements containing words such as &#8220;aim,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and other similar expressions. Such statements constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact nor are they guarantees or assurances of future performance. Forward-looking statements are based on Zai Lab&#8217;s expectations and assumptions as of the date of this press release and are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including but not limited to (1) Zai Lab&#8217;s ability to successfully commercialize and generate revenue from its approved products&#59; (2) Zai Lab&#8217;s ability to finance its operations and business initiatives and obtain funding for such activities, (3) Zai Lab&#8217;s results of clinical and pre-clinical development of its product candidates, (4) the content and timing of decisions made by the relevant regulatory authorities regarding regulatory approvals of Zai Lab&#8217;s product candidates, (5) the effects of the novel coronavirus (COVID-19) pandemic on our business and general economic, regulatory and political conditions and (6) the risk factors identified in our most recent annual or quarterly report and in other reports we have filed with the U.S. Securities and Exchange Commission. Zai Lab anticipates that subsequent events and developments will cause Zai Lab&#8217;s expectations and assumptions to change and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-right:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">events or otherwise, except as may be required by law. These forward-looking statements should not be relied upon as representing Zai Lab&#8217;s views as of any date subsequent to the date of this press release.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">For more information, please contact&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">MacroGenics Contacts</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Jim Karrels, Senior Vice President, CFO<br>1-301-251-5172<br>info&#64;macrogenics.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Zai Lab Contacts</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Billy Cho, CFO<br>+86 137 6151 2501 <br>billy.cho&#64;zailaboratory.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Media&#58; Ryo Imai &#47; Robert Flamm, Ph.D.<br>Burns McClellan, on behalf of Zai Lab<br>212-213-0006 ext. 315 &#47; 364</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">rimai&#64;burnsmc.com &#47; rflamm&#64;burnsmc.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Investors&#58; Mike Zanoni<br>Endurance Advisors, on behalf of Zai Lab<br>610-442-8570</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">mzanoni&#64;enduranceadvisors.com</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-right:18pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mgnx-20210615.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:30cd4160-e760-48d5-b5dd-5a3f14681f8b,g:d4939114-b443-463f-a3db-f3bfc26be930-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mgnx="http://macrogenics.com/20210615" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://macrogenics.com/20210615">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mgnx-20210615_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mgnx-20210615_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://macrogenics.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>mgnx-20210615_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:30cd4160-e760-48d5-b5dd-5a3f14681f8b,g:d4939114-b443-463f-a3db-f3bfc26be930-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_CurrentFiscalYearEndDate_4c910da1-b329-4f2b-815c-81c1318f0e46_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_5a0908c5-2a0b-47fa-b9a2-e500b4476d1c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_db4eda0c-4e18-4360-8b96-3d3f85d6a4a1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2a712a7a-a115-4d68-a457-77b0964150bb_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_8e5535d3-9352-4df1-9883-ddaa3ee48068_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_a401b15f-08cd-42dc-b120-1d94de93daf9_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_c04ecdaa-2d99-4654-a259-c446ae7a989e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0f66f8d4-1513-4378-afb6-fd7a8d524110_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_0bcb20bb-ceb8-4e90-80c5-0dba4fa62aff_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_40425252-4890-4145-83a0-25df8694d93f_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_f0b40a79-d609-41c3-93fc-c2db7300f537_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_82a9e9bc-b4c5-4f86-96b1-5c4d8ea70b66_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3f207645-0508-467e-ac0e-f454870ed718_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_c11e5e42-f982-4e6a-92c8-2a35fa9c52f5_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_ff91ff85-6bf5-415f-9c6b-daf90ba3d98b_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_e89abe26-d518-4820-9683-755f037eef40_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_04bd041b-b0df-46e3-b2a9-07789c821ff7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_1a6af829-5be3-46bf-8014-bdd1ffe0da17_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_887baf1a-da92-4feb-93eb-9f23bf4e6f93_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_0d16e9cc-f0a4-4ffb-8515-d2260ae7a535_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_51e63bb7-9053-4663-b84d-dfa6d8e51524_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_96d56bf6-35f5-452d-8724-c09c056a97d1_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_b1f5dddd-74c2-4fcc-9b64-8f09df4931b6_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>mgnx-20210615_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:30cd4160-e760-48d5-b5dd-5a3f14681f8b,g:d4939114-b443-463f-a3db-f3bfc26be930-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://macrogenics.com/role/Cover" xlink:type="simple" xlink:href="mgnx-20210615.xsd#Cover"/>
  <link:presentationLink xlink:role="http://macrogenics.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f2cb95d8-3db4-4383-999a-6b17269be58b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_DocumentType_f2cb95d8-3db4-4383-999a-6b17269be58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9559335d-86bd-4c1b-a012-837543bb32ea" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_DocumentPeriodEndDate_9559335d-86bd-4c1b-a012-837543bb32ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_32169298-742d-4cbf-ba4c-602477ec0511" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_EntityRegistrantName_32169298-742d-4cbf-ba4c-602477ec0511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ecc66e8c-ca0c-4547-89ac-1412cf37dd3c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ecc66e8c-ca0c-4547-89ac-1412cf37dd3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b2f0cb49-f06d-4d52-8cb2-b5fe70a4dba7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_EntityFileNumber_b2f0cb49-f06d-4d52-8cb2-b5fe70a4dba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_79d55b3d-dc24-43f7-bcbd-06a5fa9b764a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_EntityTaxIdentificationNumber_79d55b3d-dc24-43f7-bcbd-06a5fa9b764a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_df9ca0f3-a1df-4599-b35f-ac9469ff5214" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_EntityAddressAddressLine1_df9ca0f3-a1df-4599-b35f-ac9469ff5214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_18dbe092-b3cd-4f34-9d78-d941db320f2d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_EntityAddressCityOrTown_18dbe092-b3cd-4f34-9d78-d941db320f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_af109770-9be5-4a27-8098-4a91c4112731" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_EntityAddressStateOrProvince_af109770-9be5-4a27-8098-4a91c4112731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_b363572f-cbf9-461c-a92d-20c19cfd47df" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_EntityAddressPostalZipCode_b363572f-cbf9-461c-a92d-20c19cfd47df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_eae70d81-6d2f-485d-a6f4-130103c15cd3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_CityAreaCode_eae70d81-6d2f-485d-a6f4-130103c15cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_dd12d40b-a112-4d90-92b8-e21079b59e17" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_LocalPhoneNumber_dd12d40b-a112-4d90-92b8-e21079b59e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_82661eef-cfaa-42c4-9b00-e44c5139638b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_Security12bTitle_82661eef-cfaa-42c4-9b00-e44c5139638b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_da8f3b76-9710-4b81-9af6-164f3967062a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_TradingSymbol_da8f3b76-9710-4b81-9af6-164f3967062a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_58788191-e8cf-462f-9976-08add0c21f40" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_SecurityExchangeName_58788191-e8cf-462f-9976-08add0c21f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_41adb76b-a006-4435-bc06-391de540b3ce" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_WrittenCommunications_41adb76b-a006-4435-bc06-391de540b3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_1ef75fa5-baf2-441f-a80c-619ff89b0181" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_SolicitingMaterial_1ef75fa5-baf2-441f-a80c-619ff89b0181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_f989928f-38ba-45c4-9669-a09309ef6946" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_PreCommencementTenderOffer_f989928f-38ba-45c4-9669-a09309ef6946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_5624033e-0257-4a82-aa94-5aec3cfc0ca1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_5624033e-0257-4a82-aa94-5aec3cfc0ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_9329bcdc-4b98-4d45-aaf5-0c1817378a1e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_EntityEmergingGrowthCompany_9329bcdc-4b98-4d45-aaf5-0c1817378a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_d3e0ac0a-6ad0-4fd8-bcad-62dd7081506f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_EntityCentralIndexKey_d3e0ac0a-6ad0-4fd8-bcad-62dd7081506f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f281d8d1-6ae7-4812-84bd-fa54e7877131" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_AmendmentFlag_f281d8d1-6ae7-4812-84bd-fa54e7877131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_7bb6defb-9ac5-4000-9625-14134481f18a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac6905a2-a877-4b2a-a11e-cf3f6da307b4" xlink:to="loc_dei_CurrentFiscalYearEndDate_7bb6defb-9ac5-4000-9625-14134481f18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>mgnx-20210615_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mgnx-20210615.xsd" xlink:type="simple"/>
    <context id="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125345</identifier>
        </entity>
        <period>
            <startDate>2021-06-15</startDate>
            <endDate>2021-06-15</endDate>
        </period>
    </context>
    <context id="iac630aa87ea54dd0837bf59c917fa538_D20210513-20210513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125345</identifier>
        </entity>
        <period>
            <startDate>2021-05-13</startDate>
            <endDate>2021-05-13</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV80L2ZyYWc6Zjg1YzY1OGYwZWFlNDUxMDhlMTYzMmMzMzg5NjZiMDYvdGFibGU6NDU5MzJiMjM5OWQ3NGNjYzg2YjU3NDMxNzdjNjIzODAvdGFibGVyYW5nZTo0NTkzMmIyMzk5ZDc0Y2NjODZiNTc0MzE3N2M2MjM4MF8yLTEtMS0xLTA_3a7039c2-cd68-40b4-8458-d66474e217a0">0001125345</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV80L2ZyYWc6Zjg1YzY1OGYwZWFlNDUxMDhlMTYzMmMzMzg5NjZiMDYvdGFibGU6NDU5MzJiMjM5OWQ3NGNjYzg2YjU3NDMxNzdjNjIzODAvdGFibGVyYW5nZTo0NTkzMmIyMzk5ZDc0Y2NjODZiNTc0MzE3N2M2MjM4MF8zLTEtMS0xLTA_01dd32c2-355c-4b3f-aac4-8b0db80414d9">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQ2_b5ec0961-9811-421c-8d88-90520f44c91e">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18yMzI_a4b22378-cd3c-43c7-87f0-2513f8cc59b2">2021-06-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQw_0b0e4c6b-27c0-4694-8a7b-d1445627f68a">MACROGENICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmM3ZTkyY2Q3MWQ4NDlkYTgwNjI3NmYzZmFhMTZkMDYvdGFibGVyYW5nZTpmYzdlOTJjZDcxZDg0OWRhODA2Mjc2ZjNmYWExNmQwNl8wLTAtMS0xLTA_5e1296db-3cf7-427d-9c9c-397a88ef5f61">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmM3ZTkyY2Q3MWQ4NDlkYTgwNjI3NmYzZmFhMTZkMDYvdGFibGVyYW5nZTpmYzdlOTJjZDcxZDg0OWRhODA2Mjc2ZjNmYWExNmQwNl8wLTMtMS0xLTA_c840b874-b00e-4784-9573-4ddc32f28dc6">001-36112</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmM3ZTkyY2Q3MWQ4NDlkYTgwNjI3NmYzZmFhMTZkMDYvdGFibGVyYW5nZTpmYzdlOTJjZDcxZDg0OWRhODA2Mjc2ZjNmYWExNmQwNl8wLTUtMS0xLTA_e07a881e-860f-4155-a124-79e2507b491c">06-1591613</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmM3ZTkyY2Q3MWQ4NDlkYTgwNjI3NmYzZmFhMTZkMDYvdGFibGVyYW5nZTpmYzdlOTJjZDcxZDg0OWRhODA2Mjc2ZjNmYWExNmQwNl8zLTAtMS0xLTA_56cca759-e6d8-4fce-bbb6-6c4f0a395115">9704 Medical Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmM3ZTkyY2Q3MWQ4NDlkYTgwNjI3NmYzZmFhMTZkMDYvdGFibGVyYW5nZTpmYzdlOTJjZDcxZDg0OWRhODA2Mjc2ZjNmYWExNmQwNl80LTAtMS0xLTA_b6f943d2-9b75-4cde-b515-4ad099b35758">Rockville,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmM3ZTkyY2Q3MWQ4NDlkYTgwNjI3NmYzZmFhMTZkMDYvdGFibGVyYW5nZTpmYzdlOTJjZDcxZDg0OWRhODA2Mjc2ZjNmYWExNmQwNl80LTEtMS0xLTA_63cb901f-eb5a-4b84-a73f-1a255b0111c3">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmM3ZTkyY2Q3MWQ4NDlkYTgwNjI3NmYzZmFhMTZkMDYvdGFibGVyYW5nZTpmYzdlOTJjZDcxZDg0OWRhODA2Mjc2ZjNmYWExNmQwNl80LTMtMS0xLTA_f2d38b8d-c7ba-4030-b9a2-0275a0ba0bf1">20850</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="iac630aa87ea54dd0837bf59c917fa538_D20210513-20210513"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQ3_0080d96e-2a4e-4df8-9a35-7228e011b279">301</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="iac630aa87ea54dd0837bf59c917fa538_D20210513-20210513"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQx_0c2d6536-bdb6-41cd-ab25-86ae27af4511">251-5172</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmY1ODQyYjYwNDQwNGQ5YTk1NTkzZWQ5M2RhNzc4OGIvdGFibGVyYW5nZTpmZjU4NDJiNjA0NDA0ZDlhOTU1OTNlZDkzZGE3Nzg4Yl8xLTAtMS0xLTA_f2f06d28-9109-4768-a2f9-695e279c750c">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmY1ODQyYjYwNDQwNGQ5YTk1NTkzZWQ5M2RhNzc4OGIvdGFibGVyYW5nZTpmZjU4NDJiNjA0NDA0ZDlhOTU1OTNlZDkzZGE3Nzg4Yl8xLTEtMS0xLTA_b21fed8d-0c2b-49f8-8d64-23d3ae98d17b">MGNX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGFibGU6ZmY1ODQyYjYwNDQwNGQ5YTk1NTkzZWQ5M2RhNzc4OGIvdGFibGVyYW5nZTpmZjU4NDJiNjA0NDA0ZDlhOTU1OTNlZDkzZGE3Nzg4Yl8xLTItMS0xLTA_4649c1aa-74aa-48ff-9bfd-32ee68941846">NASDAQ</dei:SecurityExchangeName>
    <dei:WrittenCommunications
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQ4_79f7b69f-19e5-411b-91ea-bbb84460a4df">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQy_afaa3101-c680-475f-b9d8-ac737826128e">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQz_62072e81-f757-4b20-8b5f-b3c8a7a1fd5d">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQ0_b36b260b-0be7-4512-bf8b-edb1c2d80b13">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3MWE2N2I4ZWRmNDQ5NWI5OTIzYWM1ZWJjMjUwYzNlL3NlYzozNzFhNjdiOGVkZjQ0OTViOTkyM2FjNWViYzI1MGMzZV8xL2ZyYWc6MzkxMmUwNTg0MGQ1NGUzNDhhZGUzMDJjMDYzYmU0YzcvdGV4dHJlZ2lvbjozOTEyZTA1ODQwZDU0ZTM0OGFkZTMwMmMwNjNiZTRjN18xNjQ1_e813195a-e881-4fb3-9e00-ba14308013b4">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140414692851032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 15, 2021</div></th>
<th class="th"><div>May 13, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 15,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MACROGENICS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">06-1591613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9704 Medical Center Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rockville,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">251-5172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MGNX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001125345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M -Q?*66. [M/+7^7&/P+4$L#!!0    ( .F&T%*?H!OPL0(  .(,   -
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MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^
MKSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE
M?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @
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M 5!+ 0(4 Q0    ( .F&T%('04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ Z8;04J;$LH?N    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ Z8;04IE<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " #IAM!24W-D^$<$  "C$   &
M        @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ Z8;04I^@&_"Q @  X@P   T              ( !B@P  'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " #IAM!2EXJ[',     3 @  "P
M@ %F#P  7W)E;',O+G)E;'-02P$"% ,4    " #IAM!2JL0B%C,!   B @
M#P              @ %/$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
MZ8;04B0>FZ*M    ^ $  !H              ( !KQ$  'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ Z8;04F60>9(9 0  SP,  !,
M             ( !E!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D
,"0 ^ @  WA,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mgnx-20210615.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://macrogenics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="mgnx-20210615.htm">mgnx-20210615.htm</File>
    <File>mgnx-20210615.xsd</File>
    <File>mgnx-20210615_lab.xml</File>
    <File>mgnx-20210615_pre.xml</File>
    <File>mgnx_zlabxjointreleasex16j.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mgnx-20210615.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 2,
   "dts": {
    "inline": {
     "local": [
      "mgnx-20210615.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mgnx-20210615_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mgnx-20210615_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "mgnx-20210615.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "mgnx",
   "nsuri": "http://macrogenics.com/20210615",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mgnx-20210615.htm",
      "contextRef": "idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://macrogenics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mgnx-20210615.htm",
      "contextRef": "idb45384c33bc40d6b0ed81c280e2c7a2_D20210615-20210615",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001125345-21-000087-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001125345-21-000087-xbrl.zip
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M6@ENY#[ZH#1X.@R41A1SQ3U*&1\%7)QG6/" _H#G.L2YO\BB_%GA%!_.7_V
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MUR55-Z[7MNN <#9+1%(DZ=4?IBKD"9M-->08LH@"&4*S\D7";B1K 80O>11
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MH/W5]#E7]CR$,HKL5/7#?'ZG\DO[-W3Y)ZU-.=2:(JUC D*NS6K1GE&B(N3
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M]$FU99*)C$8$M9A&7!*'C(;:C&)'M(N>9SZ.3<DC#X:UP/ / LG+Q=TQ(ET
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MQ'M3=@27HUW! <:,9W,"P$5(9M\,ZH=#D:7>5RA!J.1%KJF?&^[6SP$6-S@
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MN/N';BG[F>5G$ZBP >GE_\7&^+J)X([[7_?P_T3H\;\!4$L! A0#%     @
MZ8;04F#]!)OV'@  ,;8  !$              ( !     &UG;G@M,C R,3 V
M,34N:'1M4$L! A0#%     @ Z8;04J^W_Y=S @  =P<  !$
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?97@Q-FHN:'1M4$L%!@     %  4 4 $  '%&      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
